R

Replicate Bioscience, Inc.

19 employees

Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science
Therapeutics
Health Care

Date founded

2020

Funding rounds raised

Total raised

$40M

from 2 investors over 2 rounds

R

Replicate Bioscience, Inc. raised $40M on September 8, 2021

Investors: ATP (Apple Tree Partners)

R

Replicate Bioscience, Inc. raised $6M on February 16, 2021

Investors: ATP (Apple Tree Partners)

FAQ